Global Metagenomic Sequencing Market Growth (Status and Outlook) 2023-2029
Metagenomics is the study of genetic material recovered directly from environmental samples. The broad field may also be referred to as environmental genomics, ecogenomics or community genomics. As the price of DNA sequencing continues to fall, metagenomics now allows microbial ecology to be investigated at a much greater scale and detail than before.
LPI (LP Information)' newest research report, the “Metagenomic Sequencing Industry Forecast” looks at past sales and reviews total world Metagenomic Sequencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Metagenomic Sequencing sales for 2023 through 2029. With Metagenomic Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metagenomic Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Metagenomic Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metagenomic Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metagenomic Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metagenomic Sequencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metagenomic Sequencing.
The global Metagenomic Sequencing market size is projected to grow from US$ 870.1 million in 2022 to US$ 1691.2 million in 2029; it is expected to grow at a CAGR of 10.0% from 2023 to 2029.
The data generated by metagenomics experiments are both enormous and inherently noisy, containing fragmented data representing as many as 10,000 species. The sequencing of the cow rumen metagenome generated 279 giga bases, or 279 billion base pairs of nucleotide sequence data, while the human gut microbiome gene catalog identified 3.3 million genes assembled from 567.7 gigabases of sequence data. Collecting, curating, and extracting useful biological information from datasets of this size represent significant computational challenges for researchers.
This report presents a comprehensive overview, market shares, and growth opportunities of Metagenomic Sequencing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Shotgun Metagenomic Sequencing
16S rRNA Sequencing
Metatranscriptomics
Whole-genome Sequencing & De Novo Assembly
Segmentation by application
Clinical Diagnostic
Environmental Remediation
Gut Microbe Characterization
Drug Discovery
Biofuel
Agriculture
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GATC Biotech
Enterome Bioscience
Illumina
Quest Diagnostics
Roche
Thermo Fisher Scientific
CLC Bio
Agilent Technologies
Macrogen
Helicos BioSciences
QIAGEN
Please note: The report will take approximately 2 business days to prepare and deliver.